论文部分内容阅读
本文对中药“494”冲剂术前用药治疗65例食管癌的临床疗效和病理观察结果作了分析。其临床用药时间短,疗效不明显,而病理形态学改变明显,与48例对照组比较有显著的差异。病理观察的重点是从癌组织生长尖端退化、癌间质反应和癌旁淋巴结反应方面观察。提示“494”对癌组织有一定的损伤作用,但非主要作用,而以提高机体免疫功能为达到抑癌的作用。同时,为中西医结合治疗食管癌提供了一种新方法。
This article analyzes the clinical efficacy and pathological observation results of 65 cases of esophageal cancer treated with Chinese medicine “494” granules preoperatively. The time of clinical use was short, the efficacy was not obvious, and the histopathological changes were obvious. There were significant differences compared with the 48 control groups. The focus of pathological observations was observed from the point of view of cancer cell growth tip degradation, cancerous interstitial reactions, and paracancerous lymph node responses. Tip “494” has a certain role in the damage of cancer, but not the main role, and to improve the body’s immune function to achieve the role of cancer suppression. At the same time, it provides a new method for the treatment of esophageal cancer with integrated traditional Chinese and Western medicine.